On this page
Nigeria carries 25 per cent of Africa’s NTD burden with all the debilitating consequences (WHO, 2016). COUNTDOWN which is an implementation research consortium, partners research specialists from the United Kingdom, United States of America, Ghana, Cameroon, Liberia, Nigeria and the Federal and some states ministries of health to generate new knowledge that will enhance increase in the reach and impact of the NTD treatment interventions in the different country-specific contexts.
The first stage of its activities was a situational analysis conducted in some communities in Kaduna and Ogun States to document strengths and weaknesses of the current NTD programme. Since then, a number of participatory action research approaches have been applied to engage different layers of stakeholders such as public health practitioners, non-governmental organisations and community-based groups such as adult men and women, young people, and boys and girls to meet the overarching objective of the partnership.
Data generated from all these engagements have been synthesised to create learning packs for school-based deworming and community-based MAM; micro planning template and participatory guide for planning MAM.
The use of these tools which are being co-created and the participatory approach of the research are being scaled up beyond the initial study sites to more areas in the 2019 MAM. This is simultaneously being evaluated, particularly the process of the use of these tools and the participatory approach and the outcomes.
Evidence from these evaluations will be presented to NTD policy makers across the relevant levels of health care in the country to inform policy changes and effective programme implementation in the country.
Phase 1: Tools and capacity strengthening: Following the creation of the tools to guide planning and implementation of programme, a working group has been constituted comprising policy makers and implementers of the NTD programme at the state and the local government levels from both states to review and advice on effective use of the tools across all relevant contexts in their states. This group in each state received capacity strengthening training which was cascaded to other implementers to ensure a paradigm shift in planning and implementation of NTD programme to a new one contained in the evidence based resources of the COUNTDOWN research starting with the 2019 MAM.
Phase 2: Evaluation: The process of using the tools and the capacity to use the participatory approach for the programme by implementers was evaluated using observational study through ethnography. The outcome of the application of the tools and the approach will be concluded using community evaluation through interviews and review meetings.
Phase 3: Engagement of stakeholders and policy makers: Evidence from both process and outcome evaluations will be presented to policy makers to inform policy changes. This will also be disseminated across relevant healthcare systems in a bid to further strengthen in-country capacity for effectively context-appropriate planning and implementation of the NTD programme.
© 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.
To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.
You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.
These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.
To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.
To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.